In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
Lower risk for MCI, dementia seen with cognitively stimulating occupations
Apr 17, 2024
Participants in a high versus low routine task intensity group had a higher risk for mild cognitive impairment and dementia.
Assisted living providers can take steps to address workforce shortages, quality, Alzheimer’s Association...
By
Lois A. Bowers
Apr 22, 2024
As federal lawmakers ponder ways to address workforce shortages and quality in senior living communities and other long-term care settings, the Alzheimer’s Association and its advocacy affiliate, the...
Distance to neurologist, PCP may explain Alzheimer’s disease disparities
Apr 05, 2024
Non-Hispanic American Indian and/or Alaska Native and Hispanic decedents have to travel further to neurologist than non-Hispanic whites.
Signed appropriations package includes $100 million funding increase for dementia research
By
Lois A. Bowers
Mar 25, 2024
A fiscal year 2024 appropriations package signed Saturday by President Biden will increase funding by $100 million for research into Alzheimer’s and other dementias at the National Institutes of Health...
Inappropriate diagnosis of pneumonia common in hospitalized adults
Mar 27, 2024
Inappropriate diagnosis is common, especially in older patients and those with dementia or an altered mental status on presentation.
Risk for adverse outcomes increased with antipsychotic use in dementia
Apr 19, 2024
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia and acute kidney injury.
Non-invasive brain stimulation might not be right for memory care residents, study warns
By
Aaron Dorman
Apr 08, 2024
Short-term, non-invasive brain stimulation might not be able to help older adults with working memory, a new study finds.
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.
American Academy of Neurology, April 13-18
Apr 23, 2024
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians, academicians, allied health professionals,...